CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Feasibility, toxicity and quality of life of 1st line chemotherapy with platinum/paclitaxel under phase III clinical trial conditions in elderly patients aged ≥ 70 years with advanced ovarian cancer – A study by the AGO OVAR Germany
DOI 10.1055/s-2006-952825
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Hilpert, A duBois, E Greimel, J Hedderich, G Krause, L Venhoff, J Pfisterer
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Today, there is evidence that despite several improvements of general health care and supportive therapies, elderly patients with advanced ovarian cancer are still not treated with the currently recommended standard carboplatin/paclitaxel. This study evaluates first-line platinum/paclitaxel under phase III trial conditions in ovarian cancer (OC) patients aged ≥ 70 years. Methods: Phase III results of 779 patie…
Zitieren
Zitierempfehlung
F Hilpert, A duBois, E Greimel, J Hedderich, G Krause, L Venhoff, J Pfisterer (2006) Feasibility, toxicity and quality of life of 1st line chemotherapy with platinum/paclitaxel under phase III clinical trial conditions in elderly patients aged ≥ 70 years with advanced ovarian cancer – A study by the AGO OVAR Germany. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-2006-952825
Mit CareLit weiterarbeiten